Epidemiology of hepatitis C virus in the Arabian Gulf countries

Systematic review and meta-analysis of prevalence

Yousra A. Mohamoud, Suzanne Riome, Laith Aburaddad

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Objective: The aims of this study were to perform a systematic review and synthesize epidemiological data on hepatitis C virus (HCV) in the Arabian Gulf countries, and to assess the country-specific prevalence among nationals and expatriate populations. Methods: A systematic review of HCV antibody prevalence and incidence in the Arabian Gulf countries was conducted, based on the items outlined in the PRISMA statement. Meta-analyses were performed incorporating inverse variance weighting and using a random-effects model to pool summary estimates of HCV prevalence among general population groups, for nationals and the entire resident population. Results: A total of 557 prevalence measures and one incidence measure were identified for the Arabian Gulf countries. HCV prevalence among nationals was 0.24% (95% confidence interval (CI) 0.02-0.63) in the United Arab Emirates (UAE), 0.44% (95% CI 0.29-0.62) in Kuwait, 0.51% (95% CI 0.43-0.59) in Qatar, and 1.65% (95% CI 1.40-1.91) in Saudi Arabia. No data were available for Bahrain or Oman. Among the entire resident populations, HCV prevalence was 0.30% (95% CI 0.23-0.38) in Bahrain, 0.41% (95% CI 0.35-0.46) in Oman, 1.06% (95% CI 0.51-1.81) in Qatar, 1.45% (95% CI 0.75-2.34) in Kuwait, 1.63% (95% CI 1.42-1.84) in Saudi Arabia, and 1.64% (95% CI 0.96-2.49) in UAE. A higher prevalence was observed among expatriate populations such as Egyptians. Among the high-risk populations, HCV prevalence was as high as 78.6% in the multi-transfused and 74.6% in people who inject drugs. Conclusions: National-level HCV prevalence in the Arabian Gulf region is comparable to global levels. A higher prevalence is found in specific expatriate populations, reflecting the prevalence in their countries of origin. Most exposures appear to occur in high-risk groups and these are often linked to medical care.

Original languageEnglish
Pages (from-to)116-125
Number of pages10
JournalInternational Journal of Infectious Diseases
Volume46
DOIs
Publication statusPublished - 1 May 2016
Externally publishedYes

Fingerprint

Hepacivirus
Meta-Analysis
Epidemiology
Confidence Intervals
Bahrain
Qatar
United Arab Emirates
Oman
Population
Kuwait
Saudi Arabia
Hepatitis C Antibodies
Incidence
Population Groups

Keywords

  • Arabian Gulf
  • Epidemiology
  • Hepatitis C virus
  • Meta-analysis
  • Prevalence
  • Systematic review

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Epidemiology of hepatitis C virus in the Arabian Gulf countries : Systematic review and meta-analysis of prevalence. / Mohamoud, Yousra A.; Riome, Suzanne; Aburaddad, Laith.

In: International Journal of Infectious Diseases, Vol. 46, 01.05.2016, p. 116-125.

Research output: Contribution to journalReview article

@article{d3e8f4fc2fea4ddbbf0585b2351cab1d,
title = "Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalence",
abstract = "Objective: The aims of this study were to perform a systematic review and synthesize epidemiological data on hepatitis C virus (HCV) in the Arabian Gulf countries, and to assess the country-specific prevalence among nationals and expatriate populations. Methods: A systematic review of HCV antibody prevalence and incidence in the Arabian Gulf countries was conducted, based on the items outlined in the PRISMA statement. Meta-analyses were performed incorporating inverse variance weighting and using a random-effects model to pool summary estimates of HCV prevalence among general population groups, for nationals and the entire resident population. Results: A total of 557 prevalence measures and one incidence measure were identified for the Arabian Gulf countries. HCV prevalence among nationals was 0.24{\%} (95{\%} confidence interval (CI) 0.02-0.63) in the United Arab Emirates (UAE), 0.44{\%} (95{\%} CI 0.29-0.62) in Kuwait, 0.51{\%} (95{\%} CI 0.43-0.59) in Qatar, and 1.65{\%} (95{\%} CI 1.40-1.91) in Saudi Arabia. No data were available for Bahrain or Oman. Among the entire resident populations, HCV prevalence was 0.30{\%} (95{\%} CI 0.23-0.38) in Bahrain, 0.41{\%} (95{\%} CI 0.35-0.46) in Oman, 1.06{\%} (95{\%} CI 0.51-1.81) in Qatar, 1.45{\%} (95{\%} CI 0.75-2.34) in Kuwait, 1.63{\%} (95{\%} CI 1.42-1.84) in Saudi Arabia, and 1.64{\%} (95{\%} CI 0.96-2.49) in UAE. A higher prevalence was observed among expatriate populations such as Egyptians. Among the high-risk populations, HCV prevalence was as high as 78.6{\%} in the multi-transfused and 74.6{\%} in people who inject drugs. Conclusions: National-level HCV prevalence in the Arabian Gulf region is comparable to global levels. A higher prevalence is found in specific expatriate populations, reflecting the prevalence in their countries of origin. Most exposures appear to occur in high-risk groups and these are often linked to medical care.",
keywords = "Arabian Gulf, Epidemiology, Hepatitis C virus, Meta-analysis, Prevalence, Systematic review",
author = "Mohamoud, {Yousra A.} and Suzanne Riome and Laith Aburaddad",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijid.2016.03.012",
language = "English",
volume = "46",
pages = "116--125",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Epidemiology of hepatitis C virus in the Arabian Gulf countries

T2 - Systematic review and meta-analysis of prevalence

AU - Mohamoud, Yousra A.

AU - Riome, Suzanne

AU - Aburaddad, Laith

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Objective: The aims of this study were to perform a systematic review and synthesize epidemiological data on hepatitis C virus (HCV) in the Arabian Gulf countries, and to assess the country-specific prevalence among nationals and expatriate populations. Methods: A systematic review of HCV antibody prevalence and incidence in the Arabian Gulf countries was conducted, based on the items outlined in the PRISMA statement. Meta-analyses were performed incorporating inverse variance weighting and using a random-effects model to pool summary estimates of HCV prevalence among general population groups, for nationals and the entire resident population. Results: A total of 557 prevalence measures and one incidence measure were identified for the Arabian Gulf countries. HCV prevalence among nationals was 0.24% (95% confidence interval (CI) 0.02-0.63) in the United Arab Emirates (UAE), 0.44% (95% CI 0.29-0.62) in Kuwait, 0.51% (95% CI 0.43-0.59) in Qatar, and 1.65% (95% CI 1.40-1.91) in Saudi Arabia. No data were available for Bahrain or Oman. Among the entire resident populations, HCV prevalence was 0.30% (95% CI 0.23-0.38) in Bahrain, 0.41% (95% CI 0.35-0.46) in Oman, 1.06% (95% CI 0.51-1.81) in Qatar, 1.45% (95% CI 0.75-2.34) in Kuwait, 1.63% (95% CI 1.42-1.84) in Saudi Arabia, and 1.64% (95% CI 0.96-2.49) in UAE. A higher prevalence was observed among expatriate populations such as Egyptians. Among the high-risk populations, HCV prevalence was as high as 78.6% in the multi-transfused and 74.6% in people who inject drugs. Conclusions: National-level HCV prevalence in the Arabian Gulf region is comparable to global levels. A higher prevalence is found in specific expatriate populations, reflecting the prevalence in their countries of origin. Most exposures appear to occur in high-risk groups and these are often linked to medical care.

AB - Objective: The aims of this study were to perform a systematic review and synthesize epidemiological data on hepatitis C virus (HCV) in the Arabian Gulf countries, and to assess the country-specific prevalence among nationals and expatriate populations. Methods: A systematic review of HCV antibody prevalence and incidence in the Arabian Gulf countries was conducted, based on the items outlined in the PRISMA statement. Meta-analyses were performed incorporating inverse variance weighting and using a random-effects model to pool summary estimates of HCV prevalence among general population groups, for nationals and the entire resident population. Results: A total of 557 prevalence measures and one incidence measure were identified for the Arabian Gulf countries. HCV prevalence among nationals was 0.24% (95% confidence interval (CI) 0.02-0.63) in the United Arab Emirates (UAE), 0.44% (95% CI 0.29-0.62) in Kuwait, 0.51% (95% CI 0.43-0.59) in Qatar, and 1.65% (95% CI 1.40-1.91) in Saudi Arabia. No data were available for Bahrain or Oman. Among the entire resident populations, HCV prevalence was 0.30% (95% CI 0.23-0.38) in Bahrain, 0.41% (95% CI 0.35-0.46) in Oman, 1.06% (95% CI 0.51-1.81) in Qatar, 1.45% (95% CI 0.75-2.34) in Kuwait, 1.63% (95% CI 1.42-1.84) in Saudi Arabia, and 1.64% (95% CI 0.96-2.49) in UAE. A higher prevalence was observed among expatriate populations such as Egyptians. Among the high-risk populations, HCV prevalence was as high as 78.6% in the multi-transfused and 74.6% in people who inject drugs. Conclusions: National-level HCV prevalence in the Arabian Gulf region is comparable to global levels. A higher prevalence is found in specific expatriate populations, reflecting the prevalence in their countries of origin. Most exposures appear to occur in high-risk groups and these are often linked to medical care.

KW - Arabian Gulf

KW - Epidemiology

KW - Hepatitis C virus

KW - Meta-analysis

KW - Prevalence

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84963958043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963958043&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2016.03.012

DO - 10.1016/j.ijid.2016.03.012

M3 - Review article

VL - 46

SP - 116

EP - 125

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -